IP Library › Granted Patent US 12,324,586
Granted Patent B2
US 12,324,586 · App. 17/521,354 · Granted Jun 10, 2025

Apparatus and methods for managing a shape of a junction between a bladder and urethra

Inventor: Bruce Choi (Raleigh, NC)
Assignee: LEVEE MEDICAL, INC.
A61B17/11A61F2/0022A61F2/0036A61B2017/1132
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,586
App. No.
17/521,354
Granted
Jun 10, 2025
Kind
B2
Abstract

The disclosure relates to apparatus and methods for managing a shape of a junction between a bladder and urethra, for example, to promote urinary continence after a prostatectomy.

Claims (37)

1. A device for mitigating urinary incontinence post prostatectomy, the device comprising:

an implant having a first portion and a second portion, wherein the first and second portions are configured to form a hollow interior area within the implant extending along a longitudinal axis thereof, wherein:

the first portion and the second portion are each configured to form a tubular shaped wall centered about the longitudinal axis,

the first portion is configured to receive a portion of a urethra therein and to be secured thereto,

the second portion is configured to receive an extended portion of a bladder therein and to be secured thereto, and

the implant is configured to encase a surgical connection of the urethra and the bladder in the hollow interior area of the implant; and

wherein the device is further configured:

to lengthen the extended portion of the bladder along the longitudinal axis by extending and narrowing the extended portion of the bladder within the hollow interior area of the device to increase effective urethral length sufficient to mitigate stress that the bladder places on one or more sphincter muscles controlling passage of liquid from the bladder to the urethra to thereby mitigate incontinence.

2. The device of claim 1 , wherein the second portion has a tapered shape about the longitudinal axis that tapers outward from a first end of the second portion to a second end of the second portion, the second end being wider than the first end.

3. The device of claim 1 , wherein the device is configured to extend and narrow the extended portion of the bladder through the second portion of the implant and into the first portion of the implant, further increasing effective urethral length.

4. The device of claim 1 , wherein the implant is compressible and configured to expand in a direction of the longitudinal axis from a compressed state to a deployed state.

5. The device of claim 4 , wherein the implant is configured to be retained in the compressed state by one or more compressing members.

6. The device of claim 1 , wherein the first portion has a distal end that is distal from the second portion, and wherein the distal end is configured to be sutured on or close to a pelvic floor associated with the urethra.

7. The device of claim 1 , wherein the implant comprises one or more loops that facilitate attaching the implant to one or more of the bladder, the urethra, and a pelvic floor.

8. The device of claim 1 , wherein the implant comprises a memory shape material.

9. The device of claim 4 , wherein the first portion and the second portion are removably coupled to one another.

10. The device of claim 1 , wherein the implant has a substantially cylindrical shape.

11. The device of claim 1 , wherein the implant comprises a tapered shape about the longitudinal axis that tapers outward from a first end of the implant to a second end of the implant, the second end being wider than the first end.

12. The device of claim 1 , wherein the implant further comprises an antibacterial biomaterial.

13. A device for mitigating urinary incontinence post prostatectomy, the device comprising:

a compressible implant configured to expand and compress along a longitudinal axis between a compressed state and an expanded state, the compressible implant having a first portion and a second portion that extend along, and are centered about, the longitudinal axis, the compressible implant forming a hollow interior area within the compressible implant that is centered about the longitudinal axis, wherein:

the first portion and the second portion are each configured to form a tubular shaped wall centered about the longitudinal axis,

the first portion is configured to receive a portion of a urethra therein, and

the second portion is configured to receive an extended portion of a bladder therein; and

wherein the compressible implant is configured to increase effective urethral length by extending and narrowing the extended portion of the bladder along the longitudinal axis while constraining the extended portion of the bladder within the hollow interior area of the compressible implant to mitigate stress that the bladder places on one or more sphincter muscles controlling passage of liquid from the bladder to the urethra and thereby mitigate incontinence.

14. The device of claim 13 , wherein the compressible implant comprises loops that facilitate securing the compressible implant to one or more of the bladder, the urethra, and a pelvic floor.

15. The device of claim 13 , wherein when the compressible implant is in the expanded state, the second portion has a tapered shape about the longitudinal axis that tapers outward from a first end of the second portion to a second end of the second portion, the second end being wider than the first end.

16. The device of claim 13 , wherein the compressible implant is configured to be retained in the compressed state along the longitudinal axis by one or more compressing members.

17. A device for mitigating urinary incontinence post prostatectomy, the device comprising:

an implant having a first portion and a second portion, wherein the first and second portions are configured to form a hollow interior area within the implant extending along a longitudinal axis thereof, wherein:

the first portion and the second portion are each configured to form a tubular shaped wall centered about the longitudinal axis,

the first portion is configured to receive a portion of a urethra therein, and

the second portion is configured to receive an extended portion of a bladder therein, the second portion extending between a proximal end of the second portion and a distal end of the second portion wherein the proximal end is proximal to the first portion and has a width that is the same as a width of the first portion, and the distal end is distal from the first portion and has a width that is wider than the first portion; and

wherein the implant is configured to lengthen the extended portion of the bladder along the longitudinal axis by extending and narrowing the extended portion of the bladder while constraining the extended portion of the bladder within the hollow interior area of the implant to mitigate stress that the bladder places on one or more sphincter muscles controlling passage of liquid from the bladder to the urethra to thereby mitigate incontinence.

18. The device of claim 17 , wherein the implant comprises loops that facilitate securing the implant to one or more of the bladder, the urethra, and a pelvic floor.

19. The device of claim 17 , wherein the implant is configured to expand and compress along the longitudinal axis between a compressed state and an expanded state.

20. The device of claim 19 , wherein the implant is configured to be retained in the compressed state by one or more compressing members.

Assignments (3)
CHANGE OF NAME Recorded Nov 14, 2024
From: LUVAURA, INC.
To: LEVEE MEDICAL, INC.
Reel/Frame 069356/0765 →
CHANGE OF NAME Recorded Dec 17, 2021
From: LUVAURA, INC
To: LEVEE MEDICAL, INC.
Reel/Frame 058800/0936 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2021
From: CHOI, BRUCE
To: LUVAURA, INC
Reel/Frame 058385/0756 →
Continuity (2)
Continuation In Part 17012555 · Sep 4, 2020
Related Publication 20220071636A1 · Mar 10, 2022
References Cited (17)
US 12150849B2 · Choi · 2024 [cited by examiner]
US 20030229364A1 · Seiba · 2003 [cited by applicant]
US 20150351767A1 · Zoll et al. · 2015 [cited by applicant]
US 20160004283A1 · Ganguly · 2016 [cited by applicant]
US 20170274123A1 · Rosell Gratacos · 2017 [cited by examiner]
WO 2016004283A1 · 2016 [cited by applicant]
David D. Childs, et al.; “Multimodality Imaging of the Male Urethra: Trauma, Infection, Neoplasm, and Common Surgical Repairs-Special section: Urothelial Disease”, published on-line (Aug. 22, 2019) pp. 3935-3949;vol. 44… [cited by applicant]
S. F. Mungovan et al., Preoperative Membranous Urethral Length Measurement and Continence Recovery Following Radical Prostatectomy: A Systematic Review and Meta-analysis (HHS Public Access, Author mainuscript, EUR Urol.… [cited by applicant]
V. W. Nitti, MD Rev Urol. 2001; 3(Suppl 1): S2-S6. The Prevalence of Urinary Incontinence (nih.gov). [cited by applicant]
Irwin et. al. BJU Int. Oct. 2011; 108(7): 1132-8 Global Forum on Incontinence, Sweden (2018) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet ob… [cited by applicant]
N. J. Sathianathen et al., An objective measurement of urinary continence recovery with pelvic floor physiotherapy following robotic assisted radical prostatectomy; Translational Andrology and Urology, vol. 6, Suppl Jul… [cited by applicant]
K. Hoyland, et al., Post-Radical Prostatectomy Incontinence: Etiology and Prevention, Reviews in Urology. vol. 16 (4); 2014 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274175/pdf/RIU016004_0181.pdf. [cited by applicant]
W.T. Lowrance et al., Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States (2012). The Journal of urology, 187(6), 2087-2092.—Abstract—Europe PMC. [cited by applicant]
B.T. Helfand, et al., Prevalence and Characteristics of Urinary Incontinence in a Treatment-Seeking Male Prospective Cohort—Results from the LURN Study; J Urol. Aug. 2018 ; 200(2): 397-404. (nih.gov). [cited by applicant]
B.S. Buckley et al., Prevalence of Urinary Incontinence in Men, Women, and Children-Current Evidence: Findings of the Fourth International Consultation on Incontinence; Urology vol. 76, Issue 2, Aug. 2010, pp. 265-270 h… [cited by applicant]
S.P. Daugirdas, et al., Urinary Incontnence and Chronic Conditions in the US Population age 50 years and older; Int Urogynecol J. Jan. 3, 2020. doi: 10.1007/s00192-019-04137-y. [cited by applicant]
Gorina Y, Schappert S, Bercovitz A, et al. Prevalence of incontinence among older Americans. National Center for Health Statistics. Vital Health Stat 3(36). 2014. https://www.cdc.gov/nchs/data/series/sr_03/sr03_036.pdf. [cited by applicant]
Cited By (1)
US 12,616,563